Picture of Medpace Holdings logo

01P Medpace Holdings News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapHigh Flyer

Medpace Holdings Inc expected to post earnings of $1.31 a share - Earnings Preview

* Medpace Holdings Inc  MEDP.OQ   MEDP.O  is expected
to show a
rise in quarterly revenue when it reports  results on July 25. 
    * The Cincinnati Ohio-based  company is expected to report 
a
23.6% increase in revenue to $344.018 million from $278.29
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Medpace Holdings
Inc is
for earnings of $1.31 per share. For the same quarter last year,
the company reported earnings of $1.06 per share.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Medpace
Holdings
Inc is $138​, below​ its last closing price of $161.40. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  1.26        1.26       1.69      Beat    34
 Dec. 31 2022  1.25        1.25       1.32      Beat    5.5
 Sep. 30 2021  1.08        1.07       1.29      Beat    20.1​
 Jun. 30 2021  0.99        0.99       1.06      Beat    7.1
 ​​Mar.        1.00        1.00       1.14      Beat    13.6
 31 2021                                                
 Dec. 31 2020  1.23        1.24       1.35      Beat    8.8​
 Sep. 30 2020  1.09        1.07       1.09      Beat    1.5
 Jun. 30 2020  0.44        0.41       0.68      Beat    64.4
 This summary was machine generated July 23 at 02:02 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Medpace Holdings

See all news